Mattison, D.R. 1991. An overview of biological markers in reproductive and developmental toxicology: Concepts, definitions and use in risk assessment. Biomedical and Environmental Sciences 4:8-34.

Merkatz, R., Temple, R., Sobel, S., Feiden, K., Kessler, D., and the Working Group on Women in Clinical Trials. 1993. New England Journal of Medicine 329(4):292-296.

Meistrich, M. 1989a. Calculations of the incidence of infertility in human populations from sperm measures using the two-distribution model. Pp. 275-290 in Institute for Health Policy Analysis Forum on Science, Health, and Environmental Risk Assessment. Alan R. Liss .

Meistrich, M. 1989b. Interspecies comparison and quantitative extrapolation of toxicity to the human male reproductive system. In Toxicology of the Male and Female Reproductive Systems, P.K. Working, ed. Bristol, Penn.: Hemisphere.

Meistrich, M., and Brown, C.C. 1983. Estimation of the increased risk of human infertility from alterations in semen characteristics. Fertility and Sterility 40(2):220-230.

Meistrich, M., and Mattison, D.R. In press. Methods for quantitative assessment of reproductive risks. In: Assessing the Risks of Adverse Reproductive Outcomes, Monograph No. 4 of the Conte Institute for Environmental Health, D. Brenner and A. Bloom, eds. March of Dimes.

Moreno, J.D. 1994. Ethical issues related to the inclusion of women of childbearing potential in clinical trials. In: Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies, Volume 2, A. Mastroianni, R. Faden, and D. Federman, eds. Washington, D.C.: National Academy Press.


NRC (National Research Council) 1983. Risk Assessment in the Federal Government: Managing the Process. Washington, D.C.: National Academy Press.

NRC. 1989. Biologic Markers in Reproductive Toxicology. Washington, D.C.: National Academy Press.


Olshein, A.R., and Mattison, D.R., eds. In press. Male-Mediated Developmental Toxicity. New York: Plenum.


Phelan, M.C., Pelloch, J.M., and Nance, W.E. 1982. Discordant expression of fetal hydantoin syndrome in heteropaternal twins. New England Journal of Medicine 307:99-101.

Planned Parenthood Federation of America. 1991. New Birth Control Conferences Report. Nine Conferences in Nine Cities: A Report, January 1990-January 1991. New York: Planned Parenthood Federation of America.


Quirk, J.G. 1986. Use and misuse of drugs in pregnancy. In: Drug and Chemical Action in Pregnancy: Pharmacologic and Toxicologic Principles, S. Fabro and A.R. Scialli, eds. New York: Marcel Dekker.


Rai, K., and Van Ryzin, J. 1985. A dose-response model for teratological experiments involving quantal responses. Biometrics 41:1-9.


Schardein, J.L. 1985. Chemically Induced Birth Defects. New York: Marcel Dekker.

Shepard, T.H. 1983. Catalog of Teratogenic Agents, 4th ed. Baltimore, Md.: Johns Hopkins University Press.

Sherwin, S. 1992. No Longer Patient. Philadelphia: Temple University Press.


Takihi, N., Rosenkranz, H.S., Klopman, G., and Mattison, D.R. In press. Structural determinants of developmental toxicity. Submitted to the Conference Proceedings for Workshop on Quantitative Methods in Developmental Toxicology, National Research Council, Washington, D.C.


Wilson, J.G., and Fraser, F.C., eds. 1979. Handbook of Teratology. New York: Plenum.

World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction and International Women's Health Coalition. 1991. Creating Common Ground: Women's Perspectives on the Selection and Introduction of Fertility Regulation Technologies. Geneva: World Health Organization.


Zar, J.H. 1984. Biostatistical Analysis. Englewood Cliffs, N.J.: Prentice-Hall.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement